Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Simpson

Showing results (241-250 of 275) with videos related to

Pageof 28
Sort By:
Haematologica|August 16, 2019
A cross-trial comparison of single-agent ibrutinib <i>versus</i> chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphomaAlessandra Tedeschi, Richard Greil, Fatih Demirkan, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous systemScott L Letendre, Jennifer Marquie-Beck, Ronald J Ellis, et al.
Stem Cells (Dayton, Ohio)|October 30, 2018
Enhanced Function of Induced Pluripotent Stem Cell-Derived Endothelial Cells Through ESM1 SignalingMarta Vilà-González, Sophia Kelaini, Corey Magee, et al.
Journal of Neurovirology|August 26, 2016
Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HANDLisa C Obermeit, Jessica Beltran, Kaitlin B Casaletto, et al.
Blood|December 8, 2018
Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter studyJorge J Castillo, Gilad Itchaki, Jonas Paludo, et al.
The Journal of Clinical Investigation|November 18, 2014
Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesisMichelle Marques Howarth, David Simpson, Siu P Ngok, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 27, 2003
A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysisPatricia Lani Lee, Constantin T Yiannoutsos, Thomas Ernst, et al.
Blood|July 26, 2019
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLLConstantine S Tam, Judith Trotman, Stephen Opat, et al.
Ear and Hearing|April 5, 2023
Aided Cortical Auditory Evoked Potentials in Infants With Frequency-Specific Synthetic Speech Stimuli: Sensitivity, Repeatability, and FeasibilityAnisa S Visram, Michael A Stone, Suzanne C Purdy, et al.
Haematologica|June 9, 2018
Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2Paul M Barr, Tadeusz Robak, Carolyn Owen, et al.
Pageof 28

Showing results (241-250 of 275) with videos related to

Sort By:
Pageof 28
Haematologica|August 16, 2019
A cross-trial comparison of single-agent ibrutinib <i>versus</i> chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphomaAlessandra Tedeschi, Richard Greil, Fatih Demirkan, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous systemScott L Letendre, Jennifer Marquie-Beck, Ronald J Ellis, et al.
Stem Cells (Dayton, Ohio)|October 30, 2018
Enhanced Function of Induced Pluripotent Stem Cell-Derived Endothelial Cells Through ESM1 SignalingMarta Vilà-González, Sophia Kelaini, Corey Magee, et al.
Journal of Neurovirology|August 26, 2016
Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HANDLisa C Obermeit, Jessica Beltran, Kaitlin B Casaletto, et al.
Blood|December 8, 2018
Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter studyJorge J Castillo, Gilad Itchaki, Jonas Paludo, et al.
The Journal of Clinical Investigation|November 18, 2014
Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesisMichelle Marques Howarth, David Simpson, Siu P Ngok, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 27, 2003
A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysisPatricia Lani Lee, Constantin T Yiannoutsos, Thomas Ernst, et al.
Blood|July 26, 2019
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLLConstantine S Tam, Judith Trotman, Stephen Opat, et al.
Ear and Hearing|April 5, 2023
Aided Cortical Auditory Evoked Potentials in Infants With Frequency-Specific Synthetic Speech Stimuli: Sensitivity, Repeatability, and FeasibilityAnisa S Visram, Michael A Stone, Suzanne C Purdy, et al.
Haematologica|June 9, 2018
Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2Paul M Barr, Tadeusz Robak, Carolyn Owen, et al.
Pageof 28